Summary & Overview
HCPCS G0101: Cervical or Vaginal Cancer Screening with Pelvic and Clinical Breast Exam
HCPCS Level II code G0101 designates a cervical or vaginal cancer screening that includes a pelvic and clinical breast examination. This preventive service plays a key role in early detection of gynecologic and breast abnormalities and is widely used in outpatient clinics, primary care and women's health settings. Nationally, G0101 supports quality measures, preventive care benchmarks, and coverage determinations that affect access to routine cancer screening.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines typical coverage and coding considerations across major national insurers and Medicare, while noting areas where policy language and preventive care guidelines can influence billing and reimbursement practices.
Readers will find a concise clinical context for the service, the typical sites where G0101 is performed, and a summary of what to expect from payer policies and benchmarking materials. Content includes service definition, common encounter settings, and implications for preventive care workflows. Data not available in the input is noted where specific payer policy details, modifier usage patterns, and associated ICD-10 diagnoses would normally appear.
Billing Code Overview
HCPCS Level II code G0101 describes a cervical or vaginal cancer screening that includes a pelvic and clinical breast examination. The service type is preventive cancer screening with physical examination, focused on pelvic exam and clinical breast exam components. The typical site of service is outpatient ambulatory settings such as physician offices, clinics, and community health centers.
Clinical & Coding Specifications
Clinical Context
A 36-year-old woman presents to a primary care or women's health clinic for her routine preventive visit. She is asymptomatic, sexually active, and due for cervical cancer screening. The clinician performs a pelvic examination, obtains a cervical cytology (Pap) specimen and/or HPV testing as indicated by screening guidelines, and performs a clinical breast examination during the same visit. Specimens are collected using appropriate collection devices and sent to the laboratory. The visit is documented with reason for visit (preventive/well-woman), informed consent for pelvic and breast exam, relevant medical and sexual history, contraceptive use, and any counseling provided. Billing uses G0101 for cervical or vaginal cancer screening that includes both the pelvic and clinical breast examination when performed during the preventive encounter. Typical workflow steps: pre-visit intake and eligibility check, vitals and brief history, clinician pelvic and breast exam, specimen collection and labeling, counseling and follow-up plan, and documentation of results and specimen routing. Typical sites of service are office-based outpatient clinics, community health centers, and federally qualified health centers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service | Use when a separate E/M visit is documented on the same day as the screening exam beyond the typical counseling for . |